Carpenter Technology heads into the second half of 2026 with short sellers retreating, options traders the most bullish they have been in months, and the Street caught in a tug-of-war over the right target after last week's earnings print.
The clearest signal this week is in short positioning — and it is decisively less bearish. Short interest has fallen 11% over the past week to 3.2% of the free float, and is down 17% over the past month. That is a meaningful unwind for a name where shorts were more present in early July, when positions ran closer to 4% of float. Lending conditions confirm there is no friction on the other side: availability is extraordinarily loose at over 4,100% — meaning there are roughly 41 shares available to borrow for every one currently short — and cost to borrow has dropped to just 0.24%, half what it was a month ago. Shorts leaving this name are doing so into a wide-open exit door.
Options positioning has flipped in the same direction. The put/call ratio has dropped to 0.80, nearly 1.7 standard deviations below its 20-day average of 1.03. A month ago the PCR was running above 1.25, near its 52-week high — traders were positioning defensively. Now, with calls clearly dominating, options flow has shifted from hedging to participation. That shift aligns neatly with the stock's 10% weekly gain to $570.66, even as closest peer surged an even sharper 22% on the week and added 12%. The aerospace and defense materials cohort caught a bid across the board; CRS was in the move, though not at its front.
The Street's reaction to Q4 results — reported July 30, when the stock dipped 2% on the day before recovering 5% over the following week — crystallised a familiar pattern: initial disappointment followed by reappraisal. Analysts mostly held ratings but split on targets. JP Morgan's Bennett Moore trimmed to $700 from $705 while keeping Overweight. Susquehanna cut to $600 from $680. Wells Fargo raised to $540, though from a lower base, maintaining Equal-Weight. BTIG moved the other way, lifting its Buy target to $620 from $450. The consensus remains a buy at a mean target of $625.88, implying roughly 10% upside from current levels — respectable, but the range from $540 to $700 reflects genuine disagreement about how fast the aerospace ramp translates into earnings. The bull case rests on disciplined margin capture in nickel superalloys for defense; the bear case flags nickel price volatility and a medical segment that has yet to regain its footing. EPS momentum factor scores rank near the top of the universe — 97th percentile on 30-day, 93rd on 90-day — suggesting estimates have been moving higher even as the PE at 37.5x and EV/EBITDA at 25x leave the valuation extended on any growth-stumble scenario.
One ownership note worth flagging: the insider activity on July 14 was a coordinated award-and-sell cycle, with the CFO, COO, General Counsel, and Chief Accounting Officer all receiving equity grants and immediately monetising portions at $576.87. Net over 90 days, insiders are positive by roughly 73,500 shares, as the award volume far outweighs the cash sales — but the sell-side of that cycle totalled over $13 million in gross proceeds. FMR (Fidelity) remains the largest external holder at 8.5% of shares, having added over 540,000 shares in the most recent reporting period.
The next scheduled catalyst is Q1 fiscal 2027 earnings on October 22. Between now and then, the dynamic to watch is whether short interest continues its month-long decline or stabilises — and whether the bullish options shift this week is the start of a durable rotation or a one-week reaction to a strong tape across the aerospace supply chain.
See the live data behind this article on ORTEX.
Open CRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
